The Journal of Pediatrics
Volume 151, Issue 1 , Pages 16-22.e3 , July 2007

Neurodevelopmental Outcomes of Premature Infants with Severe Respiratory Failure Enrolled in a Randomized Controlled Trial of Inhaled Nitric Oxide

Received 14 September 2006 ,Revised 9 January 2007 ,Accepted 12 March 2007.

References 

  1. Hack M, Friedman H, Fanaroff AA. Outcomes of extremely low birth weight infants. Pediatrics. 1996;98:931–937
  2. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics. 2001;107:e1–e8
  3. Lorenz JM, Wooliever DE, Jetton JR, Paneth N. A quantitative review of mortality and developmental disability in extremely premature newborns. Arch Pediatr Adolesc Med. 1998;152:425–435
  4. Vohr BR, Wright LL, Poole WK, McDonald SA. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks’ gestation between 1993 and 1998. Pediatrics. 2005;116:635–643
  5. Emsley HCA, Wardle SP, Sims DG, Chiswick ML, D’Souza SWD. Increased survival and deteriorating developmental outcome in 23-25 week old gestation infants, 1990-1994 compared with 1984-1989. Arch Dis Child Fetal Neonatal Ed. 1998;78:F99–F104
  6. Hack M, Fanaroff AA. Outcomes of infants of extremely low birth weight and gestational age in the 1990s. Early Hum Devel. 1999;53:193–218
  7. Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins R. Changes in neurodevelopmental outcomes at 18-22 months corrected age among infants born at less than 25 weeks gestation 1993-1999. Pediatrics. 2005;115:1645–1651
  8. Jacobs SE, O’Brien K, Inwood S, Kelly EN, Whyte HE. Outcome of infants 23-26 weeks’ gestation pre and post surfactant. Acta Paediatr. 2000;89:959–965
  9. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with respiratory distress syndrome. N Engl J Med. 2003;349:2099–2107
  10. Mestan KKL, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med. 2005;353:23–32
  11. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006;355:354–364
  12. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, et al. Improved outcome with inhaled nitric oxide in preterm infants mechanically ventilated at 7-21 days of age. N Engl J Med. 2006;355:343–353
  13. Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353:13–22
  14. Papile L, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a case study of infants with birth weights less than 1500. J Pediatr. 1978;92:529–534
  15. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33:179–201
  16. Vohr BR, Wright LL, Dusick AM, Mele L, Verter J, Steichen JJ, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics. 2000;105:1216–1226
  17. Amiel-Tison C. Neuromotor status. In:  Taeusch HW,  Yogman MW editor. Follow-up management of the high-risk infant. Boston: Little, Brown and Company; 1987;p. 115–126
  18. Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S, Jarvis S. The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol. 1989;31:341–352
  19. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–223
  20. Bayley N. Bayley Scales of Infant Development-II. San Antonio, TX: Psychological Corporation; 1993;
  21. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, et al. CDC growth charts: United States. Advance data from vital and health statistics; no. 314. Hyattsville, MD: National Center for Health Statistics 2000. Accessed at http://www/cdc/gov/growthcharts.
  22. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–706
  23. Stoll BJ, Hansen N, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely-low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357–2365
  24. Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, et al. Neurodevelopmental outcomes of extremely low birth weight infants after NEC. Pediatrics. 2005;115:696–703
  25. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. The Cochrane Database of Systematic Reviews 2006, Issue 1; CD000509.pub2.
  26. Gidday JM, Shah AR, Maceren RG, Wang Q, Pelligrino DA, Holtzman DM, et al. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab. 1999;19:331–340
  27. Kourembanas S, Mc Quillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 1993;92:99–104
  28. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol. 2005;288:L450–L459
  29. Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med. 2005;172:899–906

 INO Therapeutics provided the study gas, gas delivery systems, and site monitoring for all hospitals, and capitation funding for the hospital outside the NICHD Neonatal Research Network. The company was otherwise not involved in the study design, data analysis, data interpretation, or preparation of manuscripts.See funding information available at www.jpeds.com.

PII: S0022-3476(07)00255-7

doi: 10.1016/j.jpeds.2007.03.017

The Journal of Pediatrics
Volume 151, Issue 1 , Pages 16-22.e3 , July 2007

Article Tools

* Image Usage & Resolution